Clinical Research Directory
Browse clinical research sites, groups, and studies.
Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study
Sponsor: Erasmus Medical Center
Summary
This study aims to determine real-life clinical efficacy of virally suppressed patienst switching to DTG/3TC compared to DTG triple drug cART controls
Official title: Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2040
Start Date
2019-11-01
Completion Date
2026-11-01
Last Updated
2024-12-20
Healthy Volunteers
No
Conditions
Interventions
Dolutegravir / Lamivudine Pill
HIVRNA suppressed patients without documented M184V mutation in HIV RT and who are hepatitis B immune or have no risk factors for acquiring hepatitis B
Locations (9)
Rijnstate Hospital
Arnhem, Netherlands
Catharina Ziekenhuis
Eindhoven, Netherlands
Medisch Spectrum Twente
Enschede, Netherlands
Admiraal de Ruyter Ziekenhuis
Goes, Netherlands
Spaarne Gasthuis
Haarlem, Netherlands
Erasmus MC
Rotterdam, Netherlands
MC Haaglanden
Rotterdam, Netherlands
Maasstad Hospital
Rotterdam, Netherlands
Elisabeth Tweesteden Hospital
Tilburg, Netherlands